|
VPS26B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.696400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.992600E-01 |
| Normal-vs-Stage2 |
1.611390E-01 |
| Normal-vs-Stage3 |
4.320200E-01 |
| Normal-vs-Stage4 |
4.772200E-01 |
| Stage1-vs-Stage2 |
7.106100E-02 |
| Stage1-vs-Stage3 |
2.535400E-01 |
| Stage1-vs-Stage4 |
3.437000E-01 |
| Stage2-vs-Stage3 |
4.503600E-01 |
| Stage2-vs-Stage4 |
4.181400E-01 |
| Stage3-vs-Stage4 |
9.435800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.979400E-01 |
| Normal-vs-AfricanAmerican |
4.195800E-01 |
| Normal-vs-Asian |
7.515600E-01 |
| Caucasian-vs-AfricanAmerican |
6.032200E-01 |
| Caucasian-vs-Asian |
8.933600E-01 |
| AfricanAmerican-vs-Asian |
9.439600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.607200E-01 |
| Normal-vs-Female |
6.021200E-01 |
| Male-vs-Female |
1.584300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.137000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.094400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.450200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.898230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.364800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.579400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.857200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.136000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.347400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.342600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.584820E-01 |
| Normal-vs-Grade 2 |
7.295800E-01 |
| Normal-vs-Grade 3 |
5.931200E-01 |
| Normal-vs-Grade 4 |
4.288000E-01 |
| Grade 1-vs-Grade 2 |
6.095800E-02 |
| Grade 1-vs-Grade 3 |
4.504400E-02 |
| Grade 1-vs-Grade 4 |
3.792300E-02 |
| Grade 2-vs-Grade 3 |
7.490000E-01 |
| Grade 2-vs-Grade 4 |
5.044200E-01 |
| Grade 3-vs-Grade 4 |
6.929400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.102200E-01 |
| Normal-vs-ccB subtype |
3.524200E-01 |
| ccA subtype-vs-ccB subtype |
7.198200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.448600E-01 |
| Normal-vs-N1 |
9.726000E-01 |
| N0-vs-N1 |
6.036400E-01 |
|
|
